These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 18366514)

  • 21. Opioid dependence - management in general practice.
    Frei M
    Aust Fam Physician; 2010 Aug; 39(8):548-52. PubMed ID: 20877747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of pain in methadone-maintained patients.
    Scimeca MM; Savage SR; Portenoy R; Lowinson J
    Mt Sinai J Med; 2000; 67(5-6):412-22. PubMed ID: 11064492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methadone is safe for treating hospitalized patients with severe pain.
    Shir Y; Rosen G; Zeldin A; Davidson EM
    Can J Anaesth; 2001 Dec; 48(11):1109-13. PubMed ID: 11744587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sociodemographic disparities in supplemental service utilization among male methadone patients.
    Wu E; El-Bassel N; Gilbert L; Piff J; Sanders G
    J Subst Abuse Treat; 2004 Apr; 26(3):197-202. PubMed ID: 15063913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [One year follow-up of methadone maintenance patients].
    Facy F
    Rev Epidemiol Sante Publique; 1997 Jun; 45(3):260-1. PubMed ID: 9280990
    [No Abstract]   [Full Text] [Related]  

  • 26. Neurobiology of addictive behaviors and its relationship to methadone maintenance.
    Stimmel B; Kreek MJ
    Mt Sinai J Med; 2000; 67(5-6):375-80. PubMed ID: 11064487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementing methadone medical maintenance in community-based clinics: disseminating evidence-based treatment.
    King VL; Burke C; Stoller KB; Neufeld KJ; Peirce J; Kolodner K; Kidorf M; Brooner RK
    J Subst Abuse Treat; 2008 Oct; 35(3):312-21. PubMed ID: 18294805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effects of heroin-assisted treatment in Germany.
    Verthein U; Bonorden-Kleij K; Degkwitz P; Dilg C; Köhler WK; Passie T; Soyka M; Tanger S; Vogel M; Haasen C
    Addiction; 2008 Jun; 103(6):960-6; discussion 967-8. PubMed ID: 18422829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrating the methadone patient in the traditional addiction inpatient rehabilitation program--problems and solutions.
    Kipnis SS; Herron A; Perez J; Joseph H
    Mt Sinai J Med; 2001 Jan; 68(1):28-32. PubMed ID: 11135503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methadone as an analgesic for patients with chronic pain in methadone maintenance treatment programs (MMTPs).
    Blinderman CD; Sekine R; Zhang B; Nillson M; Shaiova L
    J Opioid Manag; 2009; 5(2):107-14. PubMed ID: 19507807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methadone in the chronic pain patient with a substance use disorder.
    Reisfield GM; Friedman CK
    J Pain Palliat Care Pharmacother; 2012 Dec; 26(4):368-70. PubMed ID: 23216175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
    Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
    J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Does maintenance treatment reduce the mortality rate of opioid addicts?].
    Scherbaum N; Specka M; Hauptmann G; Gastpar M
    Fortschr Neurol Psychiatr; 2002 Sep; 70(9):455-61. PubMed ID: 12215918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methadone: an effective alternative to morphine for pain relief in cancer patients.
    Shelton BW; Deynes-Romero J; Tofani-Montalvo M; Ramírez-Rivera J; Jaumne-Anselmi F
    Bol Asoc Med P R; 2008; 100(3):7-10. PubMed ID: 19227708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical aspects and evaluation of methadone substitution therapy].
    Déglon JJ
    Therapie; 1995; 50(6):537-42. PubMed ID: 8745953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proportional hazards frailty models for recurrent methadone maintenance treatment.
    Nosyk B; MacNab YC; Sun H; Fischer B; Marsh DC; Schechter MT; Anis AH
    Am J Epidemiol; 2009 Sep; 170(6):783-92. PubMed ID: 19671835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of methadone dispensing in Belgium--study synopsis].
    Ledoux Y
    J Pharm Belg; 2004; 59(3):69-79. PubMed ID: 15553322
    [No Abstract]   [Full Text] [Related]  

  • 38. Addiction to opioids in chronic pain patients: a literature review.
    Højsted J; Sjøgren P
    Eur J Pain; 2007 Jul; 11(5):490-518. PubMed ID: 17070082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allopathic, complementary, and alternative medical treatment utilization for pain among methadone-maintained patients.
    Barry DT; Beitel M; Cutter CJ; Garnet B; Joshi D; Schottenfeld RS; Rounsaville BJ
    Am J Addict; 2009; 18(5):379-85. PubMed ID: 19874157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.